Comments

Lexeo Therapeutics Stock Price, Quotes and Forecasts

Q: What sector and industry does Lexeo Therapeutics (LXEO) operate in?

Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

LXEONASDAQ

Logo brought to you by Benzinga Data

Perks Buy Compare Brokers

$4.38

0.5012.89%

At close: -

$4.38

0.000.00%

After Hours: 4:00 PM EDT

Lexeo Therapeutics (LXEO) Forecast

News Earnings Lexeo Therapeutics (LXEO) Options Guidance Dividends Analyst Ratings Insider Trades Short Interest

Edge Rankings

Stock Score Locked: Edge Members Only

Benzinga Rankings give you vital metrics on any stock – anytime.

Unlock Rankings

Lexeo Therapeutics Stock Price, Quotes and Forecasts | NASDAQ:LXEO | Benzinga

Explore Lexeo Therapeutics stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for LXEO.

Open	$3.98
Close	$4.38
Volume / Avg.	870.72K / 973.30K
Day Range	$3.85 - $4.40
52 Wk Range	1.45 - 19.50
Market Cap	$145.38M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	10.94%
Days to Cover	2.72

Recent News

Gene Therapy For Fatal Rare Disease-Associated Heart Condition - Lexeo Therapeutics Candidate Shows Improvements In Trials

Lexeo reported strong interim results for LX2006 in ataxia cardiomyopathy, with plans to start a registrational study by early 2026.

Vandana Singh

Pharma Frenzy: Volatility Ignites Biotech Sector

The biotechnology sector has experienced a jolt of volatility over the past few days, spearheaded by the dramatic price surges in Tonix Pharmaceuticals (NASDAQ:TNXP) and Lexeo Therapeutics (NASDAQ:LXEO). The biotech

MarketBeat

Lexeo Down Despite Upbeat Rare Disease Gene Therapy Data

Shares of Lexeo Therapeutics (NASDAQ: LXEO) lost 26% on Monday after it reported positive interim data from two cohorts of the phase I/II SUNRISE-FA study evaluating LX2006, an investigational gene therapy for treating Friedreich ataxia (FA) cardiomyopathy.

Zacks

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Jan

Mar

Apr

May

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.4

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$3.98
Close	$4.38
Volume / Avg.	870.72K / 973.30K
Day Range	$3.85 - $4.40
52 Wk Range	1.45 - 19.50
Market Cap	$145.38M
P/E Ratio	-
Dividend Yield	-
Exchange	NASDAQ
RSI	68
Short Interest	10.94%
Days to Cover	2.72

About Lexeo Therapeutics Inc.

Sector

Health Care

Industry

Biotechnology

Lexeo Therapeutics Inc is a clinical-stage genetic medicines company committed to transforming healt...

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Lexeo Therapeutics (LXEO) stock?

You can purchase shares of Lexeo Therapeutics (NASDAQ:LXEO) through any online brokerage.

View our list of the best stock brokerages

Who are Lexeo Therapeutics (LXEO) competitors?

Other companies in Lexeo Therapeutics’s space includes: Molecular Partners (NASDAQ:MOLN), Cabaletta Bio (NASDAQ:CABA), Korro Bio (NASDAQ:KRRO), Atossa Therapeutics (NASDAQ:ATOS) and Elicio Therapeutics (NASDAQ:ELTX).

What is the forecast, or price target, for Lexeo Therapeutics (LXEO) stock?

Lexeo Therapeutics has a consensus price target of $18.71.

What is the current price for Lexeo Therapeutics (LXEO)?

The stock price for Lexeo Therapeutics (NASDAQ: LXEO) is $4.38 last updated June 9, 2025 at 4:00 PM EDT.

Does Lexeo Therapeutics (LXEO) pay a dividend?

There are no upcoming dividends for Lexeo Therapeutics.

When is Lexeo Therapeutics (NASDAQ:LXEO) reporting earnings?

Lexeo Therapeutics’s Q2 earnings are confirmed for Monday, August 11, 2025.

Is Lexeo Therapeutics (LXEO) going to split?

There is no upcoming split for Lexeo Therapeutics.

What sector and industry does Lexeo Therapeutics (LXEO) operate in?

Lexeo Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.